323 related articles for article (PubMed ID: 17434881)
1. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
Rose WE; Rybak MJ; Tsuji BT; Kaatz GW; Sakoulas G
J Antimicrob Chemother; 2007 Jun; 59(6):1190-3. PubMed ID: 17434881
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus.
Tsuji BT; Rybak MJ; Lau KL; Sakoulas G
Antimicrob Agents Chemother; 2007 Mar; 51(3):1089-91. PubMed ID: 17158941
[TBL] [Abstract][Full Text] [Related]
3. Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model.
Rose WE; Kaatz GW; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2008 May; 61(5):1099-102. PubMed ID: 18263568
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?
Sakoulas G; Eliopoulos GM; Moellering RC; Novick RP; Venkataraman L; Wennersten C; DeGirolami PC; Schwaber MJ; Gold HS
J Infect Dis; 2003 Mar; 187(6):929-38. PubMed ID: 12660939
[TBL] [Abstract][Full Text] [Related]
5. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
[TBL] [Abstract][Full Text] [Related]
7. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
[TBL] [Abstract][Full Text] [Related]
8. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
10. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
Bowker KE; Noel AR; MacGowan AP
J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
[TBL] [Abstract][Full Text] [Related]
11. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.
Moise-Broder PA; Sakoulas G; Eliopoulos GM; Schentag JJ; Forrest A; Moellering RC
Clin Infect Dis; 2004 Jun; 38(12):1700-5. PubMed ID: 15227615
[TBL] [Abstract][Full Text] [Related]
12. Possible role of sarA in dehydroepiandrosterone-mediated increase in Staphylococcus aureus resistance to vancomycin.
Plotkin BJ; Konaklieva M
Chemotherapy; 2007; 53(3):181-4. PubMed ID: 17356267
[TBL] [Abstract][Full Text] [Related]
13. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
Entenza JM; Giddey M; Vouillamoz J; Moreillon P
Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Sakoulas G; Moellering RC; Eliopoulos GM
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Sader HS; Becker HK; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
[TBL] [Abstract][Full Text] [Related]
16. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
[TBL] [Abstract][Full Text] [Related]
17. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
18. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
20. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]